Anna Guidetti

7PUBLICATIONS
130CO-AUTHORS
Cardiology (incl. cardiovascular diseases)HaematologyPredictive and prognostic markersCardiovascular medicine and haematology not elsewhere classifiedCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 21, 2024
Correction: Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi

|Feb 22, 2024
Need for ICU and outcome of critically ill patients with COVID-19 and haematological malignancies: results from the EPICOVIDEHA survey.

Tobias Lahmer, Jon Salmanton-García, Francesco Marchesi

|Apr 14, 2023
Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey.

Jaap A van Doesum, Jon Salmanton-García, Francesco Marchesi

|Apr 03, 2023
Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: matched-paired analysis in the EPICOVIDEHA registry.

Francesco Marchesi, Jon Salmanton-García, Caterina Buquicchio

|Nov 17, 2022
Combination of Deauville score and quantitative positron emission tomography parameters as a predictive tool of anti-CD19 chimeric antigen receptor T-cell efficacy.

Anna Guidetti, Anna Dodero, Alice Lorenzoni

|Sep 20, 2022
Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey.

Livio Pagano, Jon Salmanton-García, Francesco Marchesi

Pageof 2

Frequent Collaborators

6 joint publications

Jon Salmanton-García

6 joint publications

Francesco Marchesi

6 joint publications

Oliver A Cornely

6 joint publications

Livio Pagano